Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 4/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14918493 | 0.91 | TSHR (0.52) | GSK3BALOX15CES1SMN1; SMN2ALDH1A1 | |
| SCHEMBL11770219 | 0.91 | CYP19A1 (0.57) | CYP19A1MCL1MAPTKDM4EGAA | |
| SCHEMBL28537498 | 0.89 | KMT2A (0.48) | GSK3BMAPTGAAMEN1KMT2A | |
| SCHEMBL1568921 | 0.89 | GSK3B (0.57) | GSK3BMAPTGAAKCNH2RECQL | |
| SCHEMBL30737542 | 0.89 | PARP10 (0.46) | GSK3BMCL1MAPTKMT2ARECQL | |
| SCHEMBL138022 | 0.89 | GSK3B (0.57) | GSK3BMAPTKDM4EKCNH2NPC1 | |
| SCHEMBL133680 | 0.89 | NPC1 (0.55) | GSK3BMAPTMEN1KMT2APTPN1 | |
| SCHEMBL8610853 | 0.89 | CYP19A1 (0.51) | GSK3BCYP19A1MCL1MAPTKDM4E | |
| SCHEMBL135383 | 0.89 | GSK3B (0.55) | GSK3BMAPTGAAKCNH2MEN1 | |
| SCHEMBL3659298 | 0.89 | TPMT (0.46) | GSK3BCYP19A1MAPTKDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101290-B2 | Organic compound having electron-transporting and/or hole-blocking performance and its use and OLEDs comprising the compound | TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF CHINESE ACADEMY OF SCIENCES (CN) | 2012-01-24 | — | — | US | disclosed |
| US-20090102356-A1 | NOVEL ORGANIC COMPOUND HAVING ELECTRON-TRANSPORTING AND/OR HOLE-BLOCKING PERFORMANCE AND ITS USE AND OLEDs COMPRISING THE COMPOUND | TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF CHINESE ACADEMY OF SCIENCES (CN) | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090102356-A1 | NOVEL ORGANIC COMPOUND HAVING ELECTRON-TRANSPORTING AND/OR HOLE-BLOCKING PERFORMANCE AND ITS USE AND OLEDs COMPRISING THE COMPOUND | SLCO4C1, SLCO1B1, SLCO2B1 | GSK3B 2732/4885CYP19A1 1973/4885MCL1 3334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.